Rader M D, Yamagata H, Reichlin M, Harley J B
J Rheumatol. 1986 Feb;13(1):79-82.
The discovery that a common systemic lupus erythematosus (SLE) autoantibody (anti-La/SSB) occurs in normal individuals has made it possible to compare the specific complement binding capacity of normal autoantibody with SLE patient autoantibody. Normal donors with elevated levels of anti-La(SSB) binding were compared to negative normal donors and to 3 patients with SLE with high levels of anti-La(SSB) binding in assays for anti-La(SSB) and for the capacity of anti-La(SSB) to bind C4. The anti-La(SSB) found in normal sera and in SLE patient sera had no identical specific capacity to fix C4. For the case of anti-La(SSB), the autoantibody structure in relation to its specific capacity to activate complement, at least to the extent of fixing C4, does not differentiate SLE patients from normal individuals with this autoantibody.
发现正常个体中存在一种常见的系统性红斑狼疮(SLE)自身抗体(抗La/SSB),这使得比较正常自身抗体与SLE患者自身抗体的特异性补体结合能力成为可能。在抗La(SSB)及其结合C4能力的检测中,将抗La(SSB)结合水平升高的正常供体与阴性正常供体以及3例抗La(SSB)结合水平高的SLE患者进行比较。正常血清和SLE患者血清中发现的抗La(SSB)结合C4的特异性能力并不相同。就抗La(SSB)而言,至少在结合C4的程度上,其自身抗体结构与其激活补体的特异性能力并不能区分携带这种自身抗体的SLE患者和正常个体。